• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The impact of ACE2 and co-factors on SARS-CoV-2 infection in colorectal cancer.

作者信息

Li Shuwei, Chen Silu, Zhu Qiuyuan, Ben Shuai, Gao Fang, Xin Junyi, Du Mulong, Chu Haiyan, Gu Dongying, Zhang Zhengdong, Wang Meilin

机构信息

Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, The Affiliated Cancer Hospital of Nanjing Medical University, Nanjing, China.

Department of Environmental Genomics, Jiangsu Key Laboratory of Cancer Biomarkers, Prevention and Treatment, Collaborative Innovation Center for Cancer Personalized Medicine, Nanjing Medical University, Nanjing, China.

出版信息

Clin Transl Med. 2022 Jul;12(7):e967. doi: 10.1002/ctm2.967.

DOI:10.1002/ctm2.967
PMID:35866260
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9305076/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c64a/9305076/8f5f82eb2840/CTM2-12-e967-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c64a/9305076/8f5f82eb2840/CTM2-12-e967-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c64a/9305076/8f5f82eb2840/CTM2-12-e967-g003.jpg

相似文献

1
The impact of ACE2 and co-factors on SARS-CoV-2 infection in colorectal cancer.ACE2及辅助因子对结直肠癌中SARS-CoV-2感染的影响
Clin Transl Med. 2022 Jul;12(7):e967. doi: 10.1002/ctm2.967.
2
SARS-CoV-2 virus associated angiotensin converting enzyme 2 expression modulation in colorectal cancer: Insights from mRNA and protein analysis COVID-19 associated (ACE2) expression in colorectal cancer.SARS-CoV-2 病毒相关的血管紧张素转换酶 2 在结直肠癌中的表达调控：来自 mRNA 和蛋白分析的见解 COVID-19 相关（ACE2）在结直肠癌中的表达。
Microb Pathog. 2023 Dec;185:106389. doi: 10.1016/j.micpath.2023.106389. Epub 2023 Oct 14.
3
Relationship Between COVID-19 and Angiotensin-Converting Enzyme 2: A Scoping Review.新型冠状病毒肺炎与血管紧张素转换酶 2 的关系：范围综述。
Adv Exp Med Biol. 2021;1321:53-68. doi: 10.1007/978-3-030-59261-5_5.
4
The pivotal link between ACE2 deficiency and SARS-CoV-2 infection: One year later.ACE2 缺乏与 SARS-CoV-2 感染之间的关键联系：一年后。
Eur J Intern Med. 2021 Nov;93:28-34. doi: 10.1016/j.ejim.2021.09.007. Epub 2021 Sep 20.
5
Angiotensin-converting Enzyme 2 Specific Cell Subset Identification in Oral Tissues: A Need of the Hour in COVID-19 Research.口腔组织中血管紧张素转换酶 2 特异性细胞亚群的鉴定：COVID-19 研究的当务之急。
J Contemp Dent Pract. 2020 Dec 1;21(12):1305-1306.
6
COVID-19 and renin-angiotensin system inhibition: role of angiotensin converting enzyme 2 (ACE2) - Is there any scientific evidence for controversy?新型冠状病毒肺炎与肾素-血管紧张素系统抑制：血管紧张素转换酶 2（ACE2）的作用-争议有何科学依据？
J Intern Med. 2020 Oct;288(4):410-421. doi: 10.1111/joim.13101. Epub 2020 Jun 8.
7
Correlation of Angiotensin-converting Enzyme 2 Gene (rs1514283) Polymorphism with the Incidence of COVID-19.血管紧张素转换酶 2 基因（rs1514283）多态性与 COVID-19 发病率的相关性。
J Popul Ther Clin Pharmacol. 2022 Jun 8;29(1):e122-e141. doi: 10.47750/jptcp.2022.922. eCollection 2022.
8
Age and gender differences in ACE2 and TMPRSS2 expressions in oral epithelial cells.口腔上皮细胞中 ACE2 和 TMPRSS2 表达的年龄和性别差异。
J Transl Med. 2021 Aug 19;19(1):358. doi: 10.1186/s12967-021-03037-4.
9
Development of a novel peptide to prevent entry of SARS-CoV-2 into lung and olfactory bulb cells of hACE2 expressing mice.研发一种新型肽，以防止 SARS-CoV-2 进入表达 hACE2 的肺和嗅球细胞的小鼠。
Mol Brain. 2022 Aug 9;15(1):71. doi: 10.1186/s13041-022-00956-1.
10
Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19.新冠病毒 2 型受体（SARS-CoV-2 receptor），血管紧张素转换酶 2 基因（angiotensin-converting enzyme 2 gene）在 COVID-19 中的表达和意义。
Mol Biol Rep. 2020 Jun;47(6):4383-4392. doi: 10.1007/s11033-020-05478-4. Epub 2020 May 14.

引用本文的文献

1
Angiotensin‑converting enzyme 2 expression in human tumors: Implications for prognosis and therapy (Review).血管紧张素转换酶2在人类肿瘤中的表达：对预后和治疗的影响（综述）
Oncol Rep. 2025 Sep;54(3). doi: 10.3892/or.2025.8934. Epub 2025 Jun 27.
2
Natural killer cell dysfunction is associated with colorectal cancer with severe COVID-19.自然杀伤细胞功能障碍与患有严重新型冠状病毒肺炎的结直肠癌有关。
World J Gastrointest Oncol. 2025 May 15;17(5):104591. doi: 10.4251/wjgo.v17.i5.104591.
3
Is COVID-19 Infection a Multiorganic Disease? Focus on Extrapulmonary Involvement of SARS-CoV-2.

本文引用的文献

1
Characteristics of SARS-CoV-2 and COVID-19.SARS-CoV-2 和 COVID-19 的特征。
Nat Rev Microbiol. 2021 Mar;19(3):141-154. doi: 10.1038/s41579-020-00459-7. Epub 2020 Oct 6.
2
The SARS-CoV-2 host cell receptor ACE2 correlates positively with immunotherapy response and is a potential protective factor for cancer progression.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的宿主细胞受体血管紧张素转换酶2（ACE2）与免疫治疗反应呈正相关，并且是癌症进展的潜在保护因素。
Comput Struct Biotechnol J. 2020;18:2438-2444. doi: 10.1016/j.csbj.2020.08.024. Epub 2020 Sep 2.
3
ACE2 correlated with immune infiltration serves as a prognostic biomarker in endometrial carcinoma and renal papillary cell carcinoma: implication for COVID-19.
新型冠状病毒肺炎感染是一种多器官疾病吗？关注严重急性呼吸综合征冠状病毒2的肺外累及情况。
J Clin Med. 2024 Feb 28;13(5):1397. doi: 10.3390/jcm13051397.
4
SARS-CoV-2 impact on ACE2 expression in NSCLC: mRNA and protein insights COVID-19 associated (ACE2) expression in non-small cell lung cancer (NSCLC).严重急性呼吸综合征冠状病毒2对非小细胞肺癌中血管紧张素转换酶2表达的影响：mRNA和蛋白质层面的见解 2019冠状病毒病相关血管紧张素转换酶2在非小细胞肺癌中的表达
Heliyon. 2023 Dec 19;10(1):e23926. doi: 10.1016/j.heliyon.2023.e23926. eCollection 2024 Jan 15.
5
Targeting ACE2-BRD4 crosstalk in colorectal cancer and the deregulation of DNA repair and apoptosis.靶向结直肠癌中ACE2-BRD4的相互作用以及DNA修复和细胞凋亡的失调。
NPJ Precis Oncol. 2023 Feb 18;7(1):20. doi: 10.1038/s41698-023-00361-4.
与免疫浸润相关的血管紧张素转换酶2作为子宫内膜癌和肾乳头状细胞癌的预后生物标志物：对2019冠状病毒病的启示
Aging (Albany NY). 2020 Apr 27;12(8):6518-6535. doi: 10.18632/aging.103100.
4
Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China.COVID-19 感染癌症患者的临床特征：中国武汉三家医院的回顾性病例研究。
Ann Oncol. 2020 Jul;31(7):894-901. doi: 10.1016/j.annonc.2020.03.296. Epub 2020 Mar 26.
5
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.严重急性呼吸系统综合征冠状病毒 2 刺突糖蛋白的结构、功能和抗原性。
Cell. 2020 Apr 16;181(2):281-292.e6. doi: 10.1016/j.cell.2020.02.058. Epub 2020 Mar 9.
6
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.严重急性呼吸综合征冠状病毒 2 型（SARS-CoV-2）进入细胞依赖于 ACE2 和 TMPRSS2，可被一种临床验证的蛋白酶抑制剂所阻断。
Cell. 2020 Apr 16;181(2):271-280.e8. doi: 10.1016/j.cell.2020.02.052. Epub 2020 Mar 5.
7
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2.全长人血管紧张素转化酶 2 识别 SARS-CoV-2 的结构基础。
Science. 2020 Mar 27;367(6485):1444-1448. doi: 10.1126/science.abb2762. Epub 2020 Mar 4.
8
Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China.新型冠状病毒肺炎（SARS-CoV-2）感染的癌症患者：一项中国全国性分析。
Lancet Oncol. 2020 Mar;21(3):335-337. doi: 10.1016/S1470-2045(20)30096-6. Epub 2020 Feb 14.
9
Tumor Mutation Burden and Prognosis in Patients with Colorectal Cancer Treated with Adjuvant Fluoropyrimidine and Oxaliplatin.结直肠癌患者接受氟嘧啶和奥沙利铂辅助治疗的肿瘤突变负担与预后。
Clin Cancer Res. 2019 Oct 15;25(20):6141-6147. doi: 10.1158/1078-0432.CCR-19-1105. Epub 2019 Jul 8.
10
Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer.肿瘤突变负担可预测 MSI-H 转移性结直肠癌对免疫检查点抑制剂的反应。
Ann Oncol. 2019 Jul 1;30(7):1096-1103. doi: 10.1093/annonc/mdz134.